Literature DB >> 29496465

Treatment of hypereosinophilic syndrome and eosinophilic dermatitis with reslizumab.

Merin Kuruvilla1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29496465     DOI: 10.1016/j.anai.2018.02.017

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  1 in total

1.  Successful Treatment of Imatinib-Induced DRESS Syndrome Using Reslizumab without Cessation of Imatinib: A Case Report.

Authors:  Hyerin Park; Gil-Soon Choi; Eun Mi Lee
Journal:  Case Rep Oncol       Date:  2021-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.